Semaglutide and Risk of Pancreatic Cancer: A Meta‐Analysis of Randomised Trials
Diabetes, Obesity and Metabolism · 2026-09 · 28 (9) · 8693-8696
DOI: 10.1111/dom.70980 ↗At a glance
Leserbrief in Diabetes, Obesity and Metabolism, published online on 2026-06-15. Written by Cho-Han Chiang and 5 co-authors. Institution: Northwell Health Cancer Institute, New Hyde Park, New York, USA. 12 references. The full text is freely available in PubMed Central.
Abstract (original language)
Intet abstract tilgængeligt.
Subjects
Author keywords
Authors and institutions
- Northwell Health Cancer Institute, New Hyde Park, New York, USA.
- Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, Massachusetts, USA.
- Department of Medicine, Danbury Hospital, Danbury, Connecticut, USA.
- Department of Medicine, University at Buffalo-Catholic Health System, Buffalo, New York, USA.
- Department of Family Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
- Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
ORCID profiles: Cho-Han Chiang, Furkan Bahar
Cite
APA
Chiang, C. H., Bahar, F., Chang, Y. C., Wang, T. H., Hsia, Y. P., & Chiang, C. H. (2026). Semaglutide and Risk of Pancreatic Cancer: A Meta‐Analysis of Randomised Trials. Diabetes, Obesity and Metabolism, 28(9), 8693-8696. https://doi.org/10.1111/dom.70980
Vancouver
Chiang CH, Bahar F, Chang YC, Wang TH, Hsia YP, Chiang CH. Semaglutide and Risk of Pancreatic Cancer: A Meta‐Analysis of Randomised Trials. Diabetes, Obesity and Metabolism. 2026;28(9):8693-8696. doi:10.1111/dom.70980
BibTeX
@article{Chiang2026,
author = {Chiang, Cho-Han and Bahar, Furkan and Chang, Yu-Cheng and Wang, Tsu Hsien and Hsia, Yuan Ping and Chiang, Cho-Hung},
title = {Semaglutide and Risk of Pancreatic Cancer: A Meta‐Analysis of Randomised Trials},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
volume = {28},
number = {9},
pages = {8693--8696},
doi = {10.1111/dom.70980}
}
EUVIMED